About this Research Topic
Acceleration of coronavirus disease (COVID-19) mass vaccination has been a chief priority for health systems globally since the first emergency approvals of COVID-19 vaccines in late 2020. Nevertheless, vaccine hesitancy (VH) which is nourished by misinformation about vaccines’ effectiveness and safety remains as a serious threat for vaccination strategies worldwide. Aversion to post-vaccination side effects, the lack of trust of pharmaceutical industry, and the lack of knowledge about vaccines’ safety are among the VH drivers; therefore independent (non-sponsored) and active surveillance of COVID-19 vaccines safety is of utmost importance for suppressing VH.
The overarching aim of this Research Topic is to synthesize a collection of the studies that evaluate the short-term side effects of different types of COVID-19 vaccines; i.e. mRNA-based, viral vector-based, inactivated virus-based, and protein subunit-based vaccines in various countries worldwide. The post-vaccination side effects can be evaluated either using the data of passive surveillance systems; e.g. VAERS, DAEN, EudraVigilance, etc or through active surveillance (epidemiological) studies; e.g. cohort, cross-sectional studies, etc.
We welcome the submission of manuscripts including, but not limited, the following topics:
• Epidemiological observational studies of the short-term side effects following COVID-19 vaccination;
• Hypothesis-driven analyses of the data of the passive surveillance systems of COVID-19 vaccines;
• Systematic reviews and meta-analyses of COVID-19 vaccines safety and effectiveness among various population groups, with a preference for the studies focusing on the people with non-communicable diseases;
• Reports of rare side effects of COVID-19 vaccines;
Keywords: Adverse Drug Reaction Reporting Systems; COVID-19 Vaccines; Pharmacovigilance; Postmarketing Product Surveillance; Side Effects
Important Note: All contributions to this Research Topic must be within the scope of the section and journal to which they are submitted, as defined in their mission statements. Frontiers reserves the right to guide an out-of-scope manuscript to a more suitable section or journal at any stage of peer review.